Skin antisepsis for reducing central venous catheter‐related infections
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Skin Antisepsis for Reducing Central Venous Catheter‐related Infections." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434810/all/Skin_antisepsis_for_reducing_central_venous_catheter‐related_infections.
Skin antisepsis for reducing central venous catheter‐related infections. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434810/all/Skin_antisepsis_for_reducing_central_venous_catheter‐related_infections. Accessed November 21, 2024.
Skin antisepsis for reducing central venous catheter‐related infections. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434810/all/Skin_antisepsis_for_reducing_central_venous_catheter‐related_infections
Skin Antisepsis for Reducing Central Venous Catheter‐related Infections [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434810/all/Skin_antisepsis_for_reducing_central_venous_catheter‐related_infections.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Skin antisepsis for reducing central venous catheter‐related infections
ID - 434810
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434810/all/Skin_antisepsis_for_reducing_central_venous_catheter‐related_infections
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -